Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-036603

AERIE PHARMACEUTICALS INC · AERI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
May 26, 2017
Accepted (ET)
May 31, 2017 · 7:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001337553

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1May 26, 2017S9,818$55.95D1,672,714ISee Footnote
Common StockF2May 26, 2017S10,182$55.95D1,950,477ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses